R&D of original antibody drugs aimed at specific targets that are relevant to the occurrence and development of tumor cells
R&D of original antibody drugs aimed at the immune checkpoints that control the immune responses of tumor cells
Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044